MXCT — MaxCyte Inc · rev $16.9M

MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.

Latest reported MXCT revenue for 2026-06-30 was $16.9M. Net income was -$13.6M. Revenue was up 75.3% from 2026-03-31 to 2026-06-30. MXCT currently screens at market cap $124.3M.

Use this MXCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MXCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MXCT SEC filings page. Lician reads the product cache first so this HTML stays unique to MaxCyte Inc even when a live quote feed is slow.